Antidiabetic Agents
Miscellaneous
Brand/Generic Name
Dosage/Strength
Status
Restrictions
Notes
Relative Cost
Bydureon
exenatide microspheres
2 mg suspension, extended rel recon
$$$
Byetta
exenatide
10 mcg/0.04 mL Pen Injector
Not Applicable
Byetta
exenatide
5 mcg/0.02 mL Pen Injector
Not Applicable
Cycloset
bromocriptine
0.8 mg tablet
Not Applicable
Invokana
canagliflozin
100 mg tablet; 300 mg tablet
Not Applicable
Symlin
pramlintide
600 mcg/mL Solution
Not Applicable
SymlinPen 120
pramlintide
2,700 mcg/2.7 mL Pen Injector
Not Applicable
SymlinPen 60
pramlintide
1,500 mcg/1.5 mL Pen Injector
Not Applicable
Victoza
liraglutide
0.6 mg/0.1 mL (18 mg/3 mL) Pen Injector
Not Applicable
WelChol
colesevelam
3.75 gram Powder in Packet
Not Applicable
WelChol
colesevelam
625 mg tablet
Not Applicable
Key for Product(s) Listed Above
Formulary
Prior Authorization (PA may not be required for some benefit plans)
Non-Formulary
(Third tier coverage applies for selected plans)
Not Reimbursed
Quantity Limit
Not available through mail order as 90-day supply*
Step Therapy
Generic Available. Brand name medication may be covered at a higher member cost or may not be covered for certain plans.
Notes
$
Relative cost compared to others in category
Specialty distribution for selected plans (Fourth or fifth tier coverage applied for selected plans)
© 2002 Managed Markets Insight and Technology, LLC. All Rights Reserved